| Literature DB >> 31842778 |
Dae Hwan Kang1, Dae Gon Ryu1, Cheol Woong Choi2, Hyung Wook Kim1, Su Bum Park1, Su Jin Kim1, Hyeong Seok Nam1.
Abstract
BACKGROUND: Upper gastrointestinal endoscopic examination is a relatively safe procedure; however, all endoscopic procedures are invasive and are associated with a risk of iatrogenic perforation. To evaluate clinical outcomes of iatrogenic upper gastrointestinal endoscopic perforation. Factors associated with surgical management or mortality were analyzed.Entities:
Keywords: Endoscopy; Iatrogenic; Mortality; Perforation; Resection
Mesh:
Year: 2019 PMID: 31842778 PMCID: PMC6916018 DOI: 10.1186/s12876-019-1139-1
Source DB: PubMed Journal: BMC Gastroenterol ISSN: 1471-230X Impact factor: 3.067
Fig. 1Flow chart showing the study design
Incidence of iatrogenic endoscopic perforations based on the types of procedures performed
| Total number of procedures, (n) | Perforation, n (%) | |
|---|---|---|
| Diagnostic endoscopy | 134,315 | 3 (0.002) |
| Endoscopic mucosal resection | 828 | 4 (0.483) |
| Esophagus | 19 | 0 (0) |
| Stomach | 396 | 0 (0) |
| Duodenum | 413 | 4 (0.968) |
| Endoscopic submucosal dissection | 2723 | 11 (0.403) |
| Esophagus | 28 | 3 (10.714) |
| Stomach | 2695 | 8 (0.296) |
| Endoscopic balloon dilation | 239 | |
| Esophagus | 186 | 0 (0) |
| Pyloric region | 53 | 0 (0) |
| Self-expandable metal stent insertion | 504 | 1 (0.198) |
| Esophagus | 177 | 1 (0.564) |
| Pyloric region | 327 | 0 (0) |
| ERCP-related procedures | 11,093 | 9 (0.081) |
| Duodenoscopic intubation | 11,093 | 3 (0.027) |
| Sphincterotomy | 4580 | 4 (0.087) |
| Ampullectomy | 29 | 2 (6.896) |
| Biliary stenting | 731 | 0 (0) |
| Total | 149,792 | 28 (0.019) |
ERCP Endoscopic retrograde cholangiopancreatography
Characteristics of patients with iatrogenic endoscopic perforations
| Characteristics | Total ( |
|---|---|
| Age, years (mean ± SD) | 65.5 (17.4) |
| Male sex, n (%) | 15 (53.6) |
| Mean hospital stay, days (mean ± SD) | 10.0 (6.0) |
| ECOG performance status, n (%) | |
| 0 | 24 (85.7) |
| 1 | 1 (3.6) |
| 2 | 3 (10.7) |
| Advanced malignancy, n (%) | 5 (17.8) |
| Pancreatic cancer | 1 (3.6) |
| Cholangiocarcinoma | 1 (3.6) |
| Duodenal adenocarcinoma | 1 (3.6) |
| Esophageal cancer | 1 (3.6) |
| Gastric cancer | 1 (3.6) |
| Site of perforation | |
| Esophagus | |
| Cervical esophagus | 2 (7.1) |
| Thoracic esophagus | 1 (3.6) |
| Lower esophagus | 5 (17.8) |
| Stomach | |
| Antrum | 2 (7.1) |
| Angle | 2 (7.1) |
| Lower body | 1 (3.6) |
| Mid body | 2 (7.1) |
| Upper body | 1 (3.6) |
| Duodenum | |
| Bulb | 2 (7.1) |
| 2nd portion | 4 (14.3) |
| Ampulla | 6 (21.4) |
ECOG Eastern Cooperative Oncology Group, SD Standard deviation
Mechanisms of iatrogenic endoscopic perforations
| Type | Number, (%) |
|---|---|
| Blunt trauma | |
| Endoscopic tip or shaft-induced injury | 6 (21.4) |
| Self-expandable metal stent-induced injury | 1 (3.6) |
| Electrocoagulation-induced injury | |
| Snare-induced | 3 (10.7) |
| Electrosurgical knife-induced | 16 (57.1) |
| Coagulation-induced | 2 (7.1) |
Fig. 2Time of diagnosis of iatrogenic endoscopic perforations
Fig. 3Clinical outcomes based on the mechanisms of iatrogenic endoscopic perforations
Factors associated with surgical operation or mortality
| Operation or mortality | Mortality | ||||||
|---|---|---|---|---|---|---|---|
| Absence ( | Operation or | Survivors ( | Death ( | Total ( | |||
| Male, n (%) | 12 (82.2) | 3 (60.0) | 0.75 | 13 (52.0) | 2 (66.7) | 15 (53.6) | 0.630 |
| Age, mean (SD) | 63.8 (17.6) | 73.2 (15.4) | 0.284 | 63.2 (17.0) | 84.3 (1.52) | 65.5 (17.4) | 0.045 |
| ECOG | 0.004 | < 0.001 | |||||
| 0 | 22 (95.7) | 2 (40.0) | 24 (96.0) | 0 (0) | 24 (85.7) | ||
| 1 | 0 (0) | 1 (20.0) | 0 (0) | 1 (33.3) | 1 (3.6) | ||
| 2 | 1 (4.3) | 2 (40.0) | 1 (4.0) | 2 (66.7) | 3 (10.7) | ||
| Advanced cancer, n (%) | 1 (4.3) | 3 (60.0) | 0.001 | 1 (4.0) | 3 (100) | 4 (14.3) | < 0.001 |
| History of gastrointestinal operation | 0 (0) | 2 (40.0) | 0.002 | 1 (4.0) | 1 (33.3) | 2 (7.1) | 0.062 |
| Site of perforation, n(%) | 0.146 | 0.254 | |||||
| Stomach | 10 (43.5) | 2 (40.0) | 11 (44.0) | 1 (33.3) | 12 (42.9) | ||
| Esophagus | 5 (21.7) | 3 (60.0) | 6 (24.0) | 2 (66.7) | 8 (28.6) | ||
| Duodenum | 8 (34.8) | 0 (0) | 8 (32.0) | 0 (0) | 8 (28.6) | ||
| Gross perforation, n(%) | 19 (82.6) | 3 (60.0) | 0.087 | 19 (76.0) | 3 (100) | 22 (78.6) | 0.632 |
| Delayed diagnosis, n (%) | 5 (21.7) | 4 (80.0) | 0.011 | 7 (28.0) | 2 (66.7) | 9 (32.1) | 0.175 |
| Blunt trauma, n (%) | 2 (8.7) | 3 (60.0) | 0.007 | 2 (8.0) | 3 (100) | 5 (17.9) | < 0.001 |
| Length of hospital stay, (days), mean (SD) | 9 (4.3) | 14 (10.3) | 0.058 | 10.1 (5.8) | 8.6 (9.0) | 10.0 (6.0) | 0.693 |
ECOG Eastern Cooperative Oncology Group, SD Standard deviation